Healios KK Ord Shs HLOSF

Healthcare Biotechnology

Healios KK is a Japan-based company mainly engaged in business in the somatic stem cell regenerative medicine field and in the iPSC regenerative medicine field, which involves research, development and manufacture of regenerative medicine products (iPSC regenerative medicines) utilizing technologies related to induced pluripotent stem cells (iPS cells, iPSCs). The somatic stem cell regenerative medicine field develops and markets cell therapy drugs for acute stroke and acute respiratory distress syndrome using MultiStem, a somatic stem cell product for which the Company holds patent and patent licensing rights. The iPSC regenerative medicines include the creation of universal donor cells (UD), next-generation iPSCs that reduce the risk of immune rejection regardless of human leukocyte antigen (HLA) type using gene editing technology.

PINL:HLOSF - Post by User

Healios KK Ord Shs > Wow

<< Previous

Bullboard Posts

Next >>

Comment by Tritoonon Apr 13, 2010 5:57am

298 Views

Post# 16984535

RE: RE: Wow

Mineralfields, according to the news releases, is one big, if not the biggest, shareholder. From their website :

https://www.mineralfields.com/index.cfm?Section=&PageId=720CB138-423B-A2BC-466442C427633D77&refresh=34EE1070-423B-A2BC-40357FB5FCF3B79B

so they are not selling.

from the nr dated nov 6 2009

https://www.halores.com/news/pdf/2009%20PRs/091106.pdf

stock offered at 5 cents, and now trading below that offering price. Does this has to do with tax advantages ?

So it looks like a lot of shares can still be offered (i hope not). Anyone know whether Mineralfields is a buyer at these prices ?

<< Previous

Bullboard Posts

Next >>

Three mispriced stocks exposed to major market tailwinds